Personalized medicine in development by type 2015

This statistic displays the percentage of personalized medicines in development by type as of 2015. In 2015, 42 percent of all drugs in development had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines. Personalized medicines are medicines that, based on a patients biomarkers or biology, may be more a effective treatment option.

Percentage of personalized medicines in development as of 2015, by type

Drug typePercentage of medicines
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2017

Region

United States

Survey time period

2015

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Personalized medicine"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.